Who was the CEO of Johnson & Johnson during the 1982 Tylenol crisis?

James E. Burke was the CEO of Johnson & Johnson during the 1982 Tylenol crisis. He had become the company’s chief executive in 1976 and remained in the role until 1989, placing him at the center of the company’s response to the poisonings.

In September and October 1982, seven people in the Chicago area died after taking Tylenol capsules laced with cyanide. The tampering occurred after the products left Johnson & Johnson’s facilities, but the company faced an enormous public-relations and safety crisis. Burke helped direct a nationwide recall of roughly 31 million bottles, an exceptionally costly decision at the time.

Johnson & Johnson then worked to restore confidence by introducing tamper-resistant packaging, including a three-layer protection system. Burke’s response is widely studied in business schools as an example of crisis management because the company prioritized consumer safety and candid communication over protecting short-term sales. Ralph S. Larsen became CEO later, in 1989; Robert Wood Johnson was a company leader from an earlier era, not the chief executive during the Tylenol poisonings.